Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 5
2022 3
2023 4
2024 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
Cornu JN, Zantek P, Burtt G, Martin C, Martin A, Springate C, Chughtai B. Cornu JN, et al. Eur Urol. 2023 Jun;83(6):534-547. doi: 10.1016/j.eururo.2023.02.028. Epub 2023 Mar 22. Eur Urol. 2023. PMID: 36964042
CONTEXT: Minimally invasive surgical therapies for male lower urinary tract symptoms secondary to benign prostatic obstruction were developed to be safer and more tolerable than standard ablative techniques. ...OBJECTIVE: To compare the efficacy, safety, and tolerab …
CONTEXT: Minimally invasive surgical therapies for male lower urinary tract symptoms secondary to benign prostatic obstruction …
New Technologies for Treatment of Benign Prostatic Hyperplasia.
Elterman D, Gao B, Lu S, Bhojani N, Zorn KC, Chughtai B. Elterman D, et al. Urol Clin North Am. 2022 Feb;49(1):11-22. doi: 10.1016/j.ucl.2021.07.007. Epub 2021 Oct 25. Urol Clin North Am. 2022. PMID: 34776045 Review.
Techniques and outcomes for BPH technologies including Aquablation, Rezum, UroLift, iTind, Optilume BPH, XFLO, Zenflow, and Butterfly are reviewed and evaluated. Given the novelty of these technologies, long-term data are required to assess safety and efficacy....
Techniques and outcomes for BPH technologies including Aquablation, Rezum, UroLift, iTind, Optilume BPH, XFLO, Zenflow, and Butterfly …
Recent Advancements in Prostate Catheters and Stents for Management of Benign Prostatic Hyperplasia.
Lama J, Winograd J, Codelia-Anjum A, Bhojani N, Elterman D, Zorn KC, Chughtai B. Lama J, et al. Curr Urol Rep. 2024 Oct 7;26(1):9. doi: 10.1007/s11934-024-01235-3. Curr Urol Rep. 2024. PMID: 39373947 Review.
PURPOSE OF REVIEW: The prevalence of benign prostatic hyperplasia (BPH) is rising, however, current treatment options present severe complications and limit patient's quality of life. Accordingly, advancements in prostatic catheter and stent designs fo …
PURPOSE OF REVIEW: The prevalence of benign prostatic hyperplasia (BPH) is rising, however, current treatment options p …
A scoping review of office-based prostatic stents: past, present, and future of true minimally invasive treatment of benign prostatic hyperplasia.
Nguyen AV, Verma I, Ferreira R, Nguyen DD, Zorn KC, Bhojani N, Lerner LB, Gauhar V, Chughtai B, Elterman DS. Nguyen AV, et al. World J Urol. 2023 Nov;41(11):2925-2932. doi: 10.1007/s00345-023-04508-7. Epub 2023 Jul 21. World J Urol. 2023. PMID: 37479913
PURPOSE: To conduct a scoping review of the existing literature and recent developments on prostatic stents for the treatment of benign prostatic hyperplasia (BPH). METHODS: A comprehensive search was performed on Embase, MEDLINE, and Web of Science to …
PURPOSE: To conduct a scoping review of the existing literature and recent developments on prostatic stents for the treatment of b …
An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device.
Elterman D, Alshak MN, Martinez Diaz S, Shore N, Gittleman M, Motola J, Pike S, Hermann C, Terens W, Kohan A, Gonzalez R, Katz A, Schiff J, Goldfischer E, Grunberger I, Tu L, Kaminetsky J, Chughtai B. Elterman D, et al. J Endourol. 2023 Jan;37(1):74-79. doi: 10.1089/end.2022.0226. Epub 2022 Oct 3. J Endourol. 2023. PMID: 36070450 Free PMC article. Clinical Trial.
Materials and Methods: Men were randomized 2:1 between iTind and sham procedure arms. The iTind was placed for 5-7 days and an 18F Foley catheter was inserted and removed for the iTind and sham group, respectively. ...There was no difference in SHIM or total …
Materials and Methods: Men were randomized 2:1 between iTind and sham procedure arms. The iTind was placed for 5-7 days and an …
Search trends in the treatment for benign prostatic hyperplasia: A twenty-year analysis.
Winograd J, Pressler M, Amanhwah K, Sze C, Punyala A, Elterman D, Zorn KC, Bhojani N, Chughtai B. Winograd J, et al. Asian J Urol. 2024 Oct;11(4):586-590. doi: 10.1016/j.ajur.2023.08.009. Epub 2023 Dec 9. Asian J Urol. 2024. PMID: 39533993 Free PMC article.
OBJECTIVE: Minimally invasive treatments for benign prostatic hyperplasia (BPH) have seen an increase in usage in recent years. We aimed to determine what types of events may influence patient search habits related to surgical BPH treatments. METHODS: Google …
OBJECTIVE: Minimally invasive treatments for benign prostatic hyperplasia (BPH) have seen an increase in usage in recen …
Office-Based Procedures for BPH.
Gao B, Lu S, Bhojani N, Zorn KC, Chughtai B, Elterman D. Gao B, et al. Curr Urol Rep. 2021 Dec 16;22(12):63. doi: 10.1007/s11934-021-01081-7. Curr Urol Rep. 2021. PMID: 34913101 Review.
PURPOSE OF REVIEW: Benign prostatic hyperplasia (BPH) is a common disease in men. A rapidly rising demand for safe and effective therapy for BPH has generated novel minimally invasive surgical treatments (MISTs). ...RECENT FINDINGS: There are three FDA-approv …
PURPOSE OF REVIEW: Benign prostatic hyperplasia (BPH) is a common disease in men. A rapidly rising demand for safe and …
Surgical treatment options for benign prostatic obstruction: beyond prostate volume.
Deyirmendjian C, Elterman D, Chughtai B, Zorn KC, Bhojani N. Deyirmendjian C, et al. Curr Opin Urol. 2022 Jan 1;32(1):102-108. doi: 10.1097/MOU.0000000000000937. Curr Opin Urol. 2022. PMID: 34669611 Review.
PURPOSE OF REVIEW: Many surgical treatment options are available for patients who present with benign prostatic obstruction (BPO). This article reviews the current treatment options available and distinguishes them based on five clinical considerations: antithrombot …
PURPOSE OF REVIEW: Many surgical treatment options are available for patients who present with benign prostatic obstruction (B …
How I Do It: Temporarily Implanted Nitinol Device (iTind).
Elterman D, Gao B, Zorn KC, Bhojani N, Chughtai B. Elterman D, et al. Can J Urol. 2021 Aug;28(4):10788-10793. Can J Urol. 2021. PMID: 34378517 Free article.
Benign prostatic hyperplasia is a common and progressive disease affecting aging men which has a significant impact on quality of life. The second-generation Temporarily Implanted Nitinol Device (iTind) is an FDA approved temporary prostatic ure …
Benign prostatic hyperplasia is a common and progressive disease affecting aging men which has a significant impact on …
The median lobe scenario. How to tackle this challenge best: systematic review and expert guidance.
Alghamlas A, Zekraoui O, Herrmann TRW, Abt D, Bach T, Chughtai B, Elterman D, Guven S, Sascha A, Kartalas-Goumas I, Scoffone CM, Bhojani N. Alghamlas A, et al. World J Urol. 2026 Jan 19;44(1):114. doi: 10.1007/s00345-025-06172-5. World J Urol. 2026. PMID: 41554936
PURPOSE: To explore the best endoscopic management for men with benign prostatic hyperplasia (BPH) and an enlarged median lobe. METHODS: A systematic search was conducted in accordance with the Joanna Briggs Institute (JBI) methodology and aligned with the Pr …
PURPOSE: To explore the best endoscopic management for men with benign prostatic hyperplasia (BPH) and an enlarged medi …
12 results